Nplate (romiplostim)

Manufacturer:

Amgen

Route of Administration:

Subcutaneous

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of thrombocytopenia in adult patients with immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
treatment of thrombocytopenia in pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
to increase survival in adults and in pediatric patients (including term neonates) acutely exposed to myelosuppressive doses of radiation

Conditions:

Immune Thrombocytopenia
Hematopoietic Syndrome of Acute Radiation Syndrome